生后人肺神经内分泌细胞的形态学观察—免疫组织化学及电镜研究

用银染色法、免疫组织化学及透射电镜技术，对３６例人肺的神经内分泌细胞进行了形态学和免疫组织化学观察。提示ＮＥ细胞发生了废用性退化，其原因可能与出生前后人肺功能改变有关。     

IL—6基因转染的瘤苗体内诱导的抗肿瘤免疫功能与效果

经丝裂霉素C体外处理后,将IL-6基因转染的、高分泌的IL-6的B16黑色素瘤细胞制成瘤苗。结果发现,体内注射IL-6基因转染的瘤苗后,小鼠脾脏CTL活性、NK活性及IL-2诱导的LAK活性显著升高。经IL-6基因转染瘤苗体内治疗后,荷瘤小鼠的皮下肿瘤生长显著减慢、肺转移结节数显著降低、存活期显著延长,若同时合用低剂量IL-2,则上述治疗效果更好。可见IL-6基因转染的瘤苗能有效地通过诱导机体抗肿瘤免疫功能而发挥抗肿瘤作用,与低剂量IL-2合用后,IL-6基因转染的瘤苗的抗肿瘤效果更佳。     

黄雀延髓层状核的传出纤维联系──HRP法研究

向４２只黄雀的延髓展状核加压注入或微电泳泳入ＨＲＰ后，在同侧的脑桥上橄榄核、对侧的脑桥外侧丘系腹核及中脑外侧核背侧部内见到密集的顺行标记终末或纤维；在双侧的延髓巨细胞核出现了大量的逆行标记细胞；在对侧的层状核内既有密集的标记终末又有一些标记细胞．结果表明：层状核的传出纤维投射到同侧上橄榄核，经外侧丘系走行至对侧的外侧丘系腹核和中脑外侧核背侧部，双侧的层状核之间也有交互投射。此外，层状核接受耳蜗亚核──双侧巨细胞核的传入投射．因此，层状核是听觉上行通路中的第二级中继站．     

子宫阔韧带内静脉的解剖学研究及其临床意义

子宫底和体上部的静脉汇集于子宫角处浅出,应称子宫上静脉。该静脉续为卵巢静脉。子宫上静脉1条者占30%,2条者占56.7%,3条者占13.3%。子宫上静脉与输卵管峡部中点相对处的口径是3.7±0.2mm,卵巢丛与子宫上静脉汇合后的口径为5.0±0.4mm。输卵管峡部中点与子宫上静脉的间距为6.3±0.6mm。在输卵管系膜中见有输卵管静脉汇入子宫上静脉。本文研究结果认为盆腔静脉淤血症的发生,与结扎手术中损伤子宫上静脉和输卵管静脉有关。     

纳米硒对断奶仔猪肝脏谷胱甘肽过氧化物酶和脱碘酶I活性的影响

研究了纳米硒和亚硒酸钠对断奶仔猪肝脏谷胱甘肽过氧化物酶和脱碘酶活性的影响。将纳米硒和亚硒酸钠2种硒源分别以0.1、0.2、0.3、0.4、0.5、1.0 mg/kg 6个硒水平添加到基础日粮中,配制成12种试验日粮,基础日粮作对照,饲养“杜长大”断奶仔猪(8.3 kg左右)。结果表明:以亚硒酸钠形式添加的硒浓度为1.0 mg/kg时,仔猪生长性能和GSH-Px活性显著低于0.2~0.4 mg/kg硒添加水平(P<0.05),纳米硒添加浓度为1.0 mg/kg,仔猪生长性能和GSH-Px活性仍然保持在高峰平台;硒源添加浓度为0.10~0.40 mg/kg时,两种硒源对GSH-Px活性的影响无显著差异(P>0.05);在0.50和1.0 mg/kg硒添加水平上,纳米硒组GSH-Px活性显著高于亚硒酸钠组(P<0.05)。基础日粮组肝脏脱碘酶活性显著低于各硒源的添加水平(P<0.05),硒源和硒添加水平对脱碘酶活性没有显著影响(P>0.05)。上述结果提示:纳米硒的Weinberg剂量-效应的最适剂量范围宽于亚硒酸钠。     

高血压病患者血清IGFⅡ的变化

目的 :探讨胰岛素样生长因子Ⅱ (IGFⅡ )与高血压病 (EH)以及与高血压伴左室肥厚 (EH伴LVH)的关系。方法 :采用放射免疫分析 10 0例未治疗的EH患者和 5 0例正常人血清IGFⅡ水平。并用彩色多普勒诊断仪测定 10 0例EH患者的左心室重量 (LVM )。结果 :EH患者血清IGFⅡ水平明显高于正常人[(0 6 6± 0 35 )ng/ml:(0 4 4± 0 14 )ng/ml,p <0 0 1],EH伴LVH者IGFⅡ高于EH非LVH者 [(0 82± 0 4 0 )ng/ml:(0 5 4± 0 2 0 )ng/ml,p <0 0 1]。结论 :EH患者IGFⅡ水平升高 ,其升高程度与病情密切相关 ,IGFⅡ可能参与了EH心肌肥厚的形成     

Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus

Equine infectious anemia virus (EIAV) is a lentivirus that causes persistent infections in horses. We hypothesized that high-avidity CTL specific for nonvariable epitopes might be associated with low viral load and minimal disease in EIAV-infected horses. To test this hypothesis, memory CTL (CTLm) responses were analyzed in two infected horses with high plasma viral loads and recurrent disease (progressors), and in two infected horses with low-to-undetectable viral loads and mild disease (nonprogressors). High-avidity CTLm in one progressor recognized an envelope gp90 epitope, and the data documented for the first time in EIAV that viral variation led to CTL escape. Each of the nonprogressors had high-to-moderate avidity CTLm directed against epitopes within Rev, including the nuclear export and nuclear localization domains. These results suggested that the epitope specificity of high- and moderate-avidity CTLm was an important determinant for disease outcome in the EIAV-infected horses examined.     

改进的小波域医学图像序列的运动估计

医学图像序列压缩是远程医疗系统中的重要技术，而运动估计在视频序列压缩中起着关键作用。我们提出了一种改进的正方形-菱形搜索算法来实现医学图像序列的运动估计。这种改进的正方形-菱形算法减少了搜索点数。我们将其应用于小波域的医学图像序列的运动估计，并对数字减影血管造影图像序列（DSA）进行实验。结果表明，改进后的小波域正方形-菱形算法较其他算法精度高。     

Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.

BACKGROUND: An antibody method based on absorption of serum with cytomegalovirus (CMV) glycoprotein B (gB) was developed for detection of infection during clinical trials of CMV gB vaccine. Previous study showed that this method detected the antibody response to infection and was negative with vaccine induced immunity. OBJECTIVES: In an ongoing efficacy trial of CMV gB vaccine the ability of the gB-absorbed CMV IgG assay to detect CMV infection was assessed and compared with viral culture results. STUDY DESIGN: Two hundred and ninety two healthy, seronegative young women in a phase II, double-blind, placebo-controlled, clinical trial of recombinant CMV gB vaccine (sanofi pasteur) with MF59 adjuvant (Chiron) were randomized to receive CMV gB vaccine or placebo (1:1) on a 0, 1 and 6 month schedule. Participants were screened every 3 months for CMV infection using the gB-absorbed CMV IgG assay, and a subgroup was also screened for infection with viral cultures. Viral culture (urine, vaginal swab and saliva) was used to confirm CMV infection in all subjects with a positive gB-absorbed CMV IgG result. RESULTS: Evidence of CMV infection (gB-absorbed CMV IgG levels>or=5.0 AU/ml) was found in 23/292 (7.88%) study participants. The gB-absorbed CMV IgG levels of their first positive serum ranged from 15.7 to 251.0 AU/ml with a mean of 77.0 AU/ml and a median of 44.9 AU/ml. Cytomegalovirus was isolated from all 23 of them from culture specimens collected after their first positive gB-absorbed CMV IgG. The time to first CMV positive culture from first positive gB-absorbed CMV IgG ranged from 0 to 12 weeks with a median of 2 weeks. CONCLUSIONS: The gB-absorbed CMV IgG assay detects CMV infection in CMV gB vaccine clinical trials earlier and more rapidly than virus culture and does not reveal whether subjects received CMV gB vaccine or placebo.